Invention Grant
- Patent Title: Biologically active peptides
-
Application No.: US16359763Application Date: 2019-03-20
-
Publication No.: US10822376B2Publication Date: 2020-11-03
- Inventor: Friedrich Scheiflinger , Michael Dockal
- Applicant: Baxalta Incorporated , Baxalta GmbH
- Applicant Address: CH Opfikon US IL Bannockburn
- Assignee: Baxalta GmbH,Baxalta Incorporated
- Current Assignee: Baxalta GmbH,Baxalta Incorporated
- Current Assignee Address: CH Opfikon US IL Bannockburn
- Agency: Morgan, Lewis & Bockius LLP
- Main IPC: C07K7/06
- IPC: C07K7/06 ; C07K14/755 ; C07K7/08 ; C07K1/04 ; A61K38/00

Abstract:
A peptide or peptide derivative comprising: (i) WDLYFEIVW (SEQ ID NO:1); or (ii) a variant amino acid sequence comprising one, two, three or four L-amino acid substitutions in WDLYFEIVW (SEQ ID NO: 1); or (iii) the retro-inverso variant of the peptide or peptide derivative of either one of parts (i) and (ii), wherein said peptide or peptide derivative has procoagulant activity. A peptide or peptide derivative comprising: (i) an amino acid sequence comprising imfwydcye; or (ii) a variant amino acid sequence comprising one, two, three, four, five or six amino acid substitutions in imfwydcye, wherein said peptide or peptide derivative has procoagulant activity.
Public/Granted literature
- US20190225648A1 BIOLOGICALLY ACTIVE PEPTIDES Public/Granted day:2019-07-25
Information query